EICHOR
● Completed
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
Condition: Active Idiopathic Inflammatory Myopathy · Myositis · Dermatomyositis · Sponsor: argenx
About this study
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy (IIM). Participants with the IIM subtypes of dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM), or certain other subtypes of polymyositis (PM; including antisynthetase syndrome \[ASyS\]) will be included in the study. Treatment response will be measured by Total improvement score (TIS).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (202)
| Neuromuscular Research Center | Phoenix, Arizona, United States | — |
| HonorHealth Neurology - Bob Bove Neuroscience Institute - Neurology | Scottsdale, Arizona, United States | — |
| Attune Health Research, Inc | Beverly Hills, California, United States | — |
| University of Southern California Norris Comprehensive Cancer Center | Los Angeles, California, United States | — |
| Profound Research LLC - Oceanside | Oceanside, California, United States | — |
| University of California, Irvine | Orange, California, United States | — |
| Eisenhower Medical Center | Rancho Mirage, California, United States | — |
| Stanford Medicine Outpatient Center - Stanford Dermatology Clinic-Stanford University School of Medicine | Redwood City, California, United States | — |
| California Pacific Medical Center - Sutter Health | San Francisco, California, United States | — |
| Amyotrophic Lateral Sclerosis (ALS) Treatment Center,University of California San Francisco (UCSF) | San Francisco, California, United States | — |
| Denver Arthritis Clinic | Denver, Colorado, United States | — |
| Yale Cancer Center-Yale University School Of Medicine | New Haven, Connecticut, United States | — |
+ 190 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05523167